• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSL0500039 重组抗CD52人源化单克隆抗体注射液 Recombinant anti-CD52 humanized monoclonal antibody Injection Biological Products(2) New Drug Application 2005-05-30 上海张江生物技术有限公司 Shanghai Zhangjiang BIOTECHNOLOGY Co Ltd Certificate Issued 2006-07-13 view
CXSL1400091 重组抗CD52人源化单克隆抗体注射液 Recombinant anti-CD52 humanized monoclonal antibody Injection Biological Products(2) New Drug Application 2014-11-25 浙江海正药业股份有限公司 Zhejiang Hisun Pharmaceutical Co Ltd Certificate Issued 2016-03-25 view
CXSL1600113 重组人源化抗CD52单克隆抗体注射液 Recombinant anti-CD52 humanized monoclonal antibody Injection Biological Products(7) New Drug Application 2017-05-03 兰州生物制品研究所有限责任公司 Lanzhou Institute of Biological Products Co Ltd Certificate Issued 2018-02-27 view